Company intelligence / Profile preview

YAAX International

Mexico City, Mexico

Ownership: Private
Employees: ~30
Development stage: Other

Overview

YAAX International is a specialty pharmaceutical company focused on providing access to innovative therapies for patients with rare and complex diseases in Latin America. The company acts as a strategic commercial partner for global biotechnology and pharmaceutical firms, managing regulatory affairs, market access, and distribution across the region. YAAX specializes in orphan drugs and high-specialty medicines in therapeutic areas such as oncology, hematology, and genetic disorders. By leveraging its local expertise and infrastructure, YAAX facilitates the entry of life-saving treatments into emerging markets.

Therapeutic areas: OncologyRare DiseasesMetabolic Disorders
Modalities: Small molecule
Industry: Biotech

Partnerships

Recordati Rare DiseasesChiesi Farmaceutici

Beyond the preview

Go deeper on YAAX International.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on YAAX International.

Explore the full profile